Trials / Unknown
UnknownNCT03420040
A Comparative Study of the Effects of QS-M Needle Free Injector and Glargine Pen Subcutaneous Injection of Insulin Glargine on Insulin Use
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 65 (estimated)
- Sponsor
- Xijing Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
A clinical study of the use of glargine insulin in 2 subjects with type two diabetes in China was carried out. The two kinds of injection methods were evaluated as subcutaneous injection of insulin glargine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | QS-M Needle Free Injector | The subjects were proficient in the two injection methods of injection of QS-M needle free syringe and Glargine pen injection |
| DEVICE | Glargine pen | The subjects were proficient in the two injection methods of injection of QS-M needle free syringe and Glargine pen injection |
Timeline
- Start date
- 2017-11-27
- Primary completion
- 2018-02-20
- Completion
- 2018-04-01
- First posted
- 2018-02-05
- Last updated
- 2018-02-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03420040. Inclusion in this directory is not an endorsement.